NorthWest Biotherapeutics Inc (NWBO)

[CherryTree1]

Come on man . . . you know he was trying to take over the company.
You neglected to mention that he insisted the engage Ondra (Katherine Fox) who tried stealing their confidential proprietary technology info . . . that was more what severed the relationship than insisting on a board member of his choice be added.
https://thefly.com/landingPageNews.php?id=2296820&headline=NWBO-NW-Bio-has-ceased-all-communications-with-Ondra-Partners

NW Bio has ceased all communications with Ondra Partners. [/b]Northwest Biotherapeutics said it has ceased working with Ondra Partners for "several reasons." It stated, "As part of the recent $30M financing, NW Bio was required to engage Ondra (with fees starting at $150,000 per month) and NW Bio did so. The engagement agreement included confidentiality provisions and requirements. The first stage of working with Ondra involved numerous requests by Ondra for all of NW Bio's internal business information, including confidential business plans, strategies, un-redacted contracts, costs and pricing information, financial models and other information. It also involved a full day of briefings to several Ondra partners in NW Bio's offices about this confidential information, with extensive notes taken by the Ondra personnel. NW Bio subsequently discovered that one of the Ondra partners who participated in the full day briefing in NW Bio's offices, taking extensive notes, and who pressed repeatedly for NW Bio's confidential business documents and information, is a Director on the Board of an Israeli company against which NW Bio's contract manufacturer has been in very intensive litigation in US Federal court for several years, for alleged extensive misappropriation of intellectual property of the manufacturer and its clients, including NW Bio. There was never any disclosure of this conflict of interest by Ondra Partners. NW Bio ceased all communications with Ondra Partners. Following Neil Woodford's filing of Form 13D on November 24, Ondra Partners also notified NW Bio that it was terminating the engagement to avoid potential conflict of interest. NW Bio is actively seeking the return of all of its sensitive confidential business information, including the extensive notes taken by Ondra personnel in the day-long briefing session and all documents or derivative information produced in Ondra based on or containing NW Bio information. All of these documents and information are required to be returned to NW Bio under the confidentiality provisions of the engagement agreement."

Read more at:
https://thefly.com/n.php?id=2296820